Unsolicited Proposal From

Related by string. * UNSOLICITED . unsolicited : unsolicited e mails . unsolicited manuscripts . unsolicited telemarketing calls . unsolicited suitor / pro posal . PROPOSALS . PROPOSAL . Proposals : Superior Proposal . proposal significantly undervalues . Merger Proposal . Indecent Proposal / fro m . Fro m . from : E MAIL FROM OUR . CASH FLOWS FROM OPERATING . FROM THOSE PROJECTED IN * *

Related by context. Frequent words. (Click for all words.) 79 Q2 Loss Narrows 78 Q3 Loss Narrows 78 Extends Tender Offer 78 Annual Meeting Date 78 Q1 Loss Narrows 76 Q2 Loss Widens 76 Lowers Guidance 76 Regains Compliance 76 Files Annual Report 76 Hostile Bid 76 Q4 Loss Narrows 75 Updates Guidance 75 Q1 Loss Widens 75 FY# Guidance 75 Q3 Profit Surges 75 CFO Resigns 75 Q4 Profit Surges 75 Q3 Loss Widens 75 Announces Organizational Changes 75 Stockholders Approve 74 Stock Buyback 74 Q4 Loss Widens 74 Share Repurchases 74 Provides Guidance 74 Announces Share Repurchase 74 Buyout Offer 74 Option Grants 74 Adopts Shareholder Rights 74 Reaffirms Guidance 74 Announces Definitive Agreement 74 Share Buyback 74 Declares Quarterly Dividends 73 Shareholder Vote 73 Forecast Quick Facts 73 CEO Exercises Options 73 Extends Offer 73 Analyst Upgrade 72 Posts Wider Loss 72 Guides Above 72 Provides Preliminary 72 Announces Stock Repurchase 72 3rd Quarter Results 72 Shares Soar 72 Revenues Decline 72 4Q Loss Widens 72 Complete Merger 72 Above Estimates 72 Shareholders Approve Merger 71 Files Patent 71 Schedules Fiscal 71 Calls Purchased 71 Hold Fourth Quarter 71 Finalizes Acquisition 71 Boosts Dividend 71 Previously Announced 71 Holds Annual Meeting 71 Net Loss Narrows 71 Q1 Profit Declines 71 1st Quarter Results 71 Announces Additions 71 Guides Q4 71 #.#/Share [002] 71 Sells Shares 71 Guides Q2 71 Shareholder Letter 71 Vertex Pharmaceuticals Announces 71 Guidance Quick Facts 71 Webcast Annual Meeting 70 Raises Guidance 70 Extends Leadership 70 Shareholder Investigation 70 Patent Lawsuit 70 Earnings Scorecard 70 Shareholders Elect 70 Stock Downgraded 70 Guides Below 70 Q4 Profit Declines 70 Posts 1Q 70 Guides Q3 70 Upcoming Investor Conference 70 Announces Enhancements 70 FDA Accepts 70 Commences Tender Offer 70 Acquire Assets 70 Narrows Loss 70 Raises Dividend 70 Bearish Pressure Building 70 Achieves Milestone 70 FDA Clears 70 Welcomes Analyst 70 Announce Completion 70 Q2 Profit Declines 70 Preliminary Fourth Quarter 69 Issues Guidance 69 Lifts FY# EPS 69 Cash Tender Offers 69 Deliver Enhanced 69 Announces Shareholder Approval 69 Record Fourth Quarter 69 Announces Intention 69 Stockholders Vote

Back to home page